Insider · CIK 0001897557
Robert Barrow
Files at DFTX (Definium Therapeutics, Inc.). First filing Dec 27, 2024, latest Sep 29, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DFTX: Definium Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Definium Therapeutics, Inc. | $1.2M 31,550 shares | -1% | - | |
| 26Weak | Definium Therapeutics, Inc. | $722k 19,023 shares | -1% | - | |
| 37Weak | Definium Therapeutics, Inc. | $451k 24,431 shares | -3% | +278% from low-3% from high | |
| 35Weak | Definium Therapeutics, Inc. | $339k 25,791 shares | -3% | +167% from low-8% from high | |
| 33Weak | Definium Therapeutics, Inc. | $252k 25,797 shares | -3% | +100% from low-4% from high | |
| 32Weak | Definium Therapeutics, Inc. | $180k 26,491 shares | -3% | +40% from low-31% from high | |
| 24Weak | Definium Therapeutics, Inc. | $143k 21,208 shares | -2% | - | |
| 31Weak | Definium Therapeutics, Inc. | $142k 19,106 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 26, 2024 | DFTX MIND MEDICINE (MINDMED) INC. | 19,106 0.03% of outstanding | $142k | Dec 26, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -31,550 | $36.57 | $1.2M | 2,213,090 | 13 d ago |
| Sep 14, 2026 | DFTX Definium Therapeutics, Inc. | AGrant or award Common Shares | +750,000 | $0.00 | $0 | 2,244,640 | 28 d ago |
| Sep 2, 2026 | DFTX Definium Therapeutics, Inc. | AGrant or award Common Shares10b5-1 | +40,000 | $0.00 | $0 | 1,513,663 | 38 d ago |
| Sep 3, 2026 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -19,023 | $37.94 | $722k | 1,494,640 | 38 d ago |
| Mar 25, 2026 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -24,431 | $18.47 | $451k | 752,454 | Mar 26, 2026 |
| Feb 3, 2026 | DFTX Definium Therapeutics, Inc. | AGrant or award Common Shares | +320,000 | $0.00 | $0 | 1,098,477 | Feb 5, 2026 |
| Dec 26, 2025 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -25,791 | $13.15 | $339k | 778,477 | Dec 29, 2025 |
| Sep 25, 2025 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -25,797 | $9.77 | $252k | 804,268 | Sep 26, 2025 |
| Jun 25, 2025 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -26,491 | $6.80 | $180k | 830,065 | Jun 26, 2025 |
| Mar 25, 2025 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -21,208 | $6.74 | $143k | 856,556 | Mar 26, 2025 |
| Mar 12, 2025 | DFTX Definium Therapeutics, Inc. | AGrant or award Common Shares | +350,000 | $0.00 | $0 | 877,764 | Mar 13, 2025 |
| Dec 26, 2024 | DFTX Definium Therapeutics, Inc. | SOpen-market sale Common Shares10b5-1 | -19,106 | $7.43 | $142k | 526,666 | Dec 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.